The Lineup is a monthly series where we're giving you an inside peek at the beauty lineups of the most sought-after experts ...

In patients with cystic fibrosis, treatment with elexacaftor-tezacaftor-ivacaftor significantly improves glycemic control with no new safety concerns.

Therapists are emphasizing the importance of family therapy to address the generational trauma that exists in the family tree. Black families specifically can benefit through group therapy given the ...

Skye shares new preclinical DIO data at virtual KOL event Nimacimab + tirzepatide demonstrates over 40% weight loss in multiple preclinical DIO ...

ZyVersa is developing Cholesterol Efflux Mediator™ VAR 200 to mediate removal of damaging excess cholesterol and other lipids from the kidneys’ ...

Germany: Researchers have found in a new study of 28,441 patients with type 2 diabetes that SGLT2 inhibitors were associated ...

Voyager Therapeutics, Inc. ( NASDAQ: VYGR) Citi's Biopharma Back to School Conference September 2, 2025 4:00 PM EDT ...

Rahway, New Jersey Wednesday, September 3, 2025, 10:00 Hrs [IST] ...

Matrixyl, a synthetic peptide known chemically as palmitoyl pentapeptide-4, has attracted considerable attention within biochemical and materials science research domains.